Drug intelligence / Profile preview

CRA_17693

Development stage
Unknown
Lead developer
Los Alamos National Security
Modality
Small Molecules
01

Overview

CRA_17693 is an experimental small molecule compound that acts as an inhibitor of Serine protease 1 (PRSS1), also known as cationic trypsinogen. It has been characterized by its activity against various synthetic substrates, including Boc-Phe-Ser-Arg-Mec, Boc-Leu-Thr-Arg-Mec, Boc-Gln-Ala-Arg-Mec, and Boc-Val-Pro-Arg-Mec. The compound is identified by the chemical formula C24H17FN4O5 and a molecular weight of 460.414 Da. While listed in databases such as DrugBank (DB01741), CRA_17693 is primarily utilized as a research tool in structural biology and biochemical studies to investigate protease-ligand interactions, particularly in the context of trypsin inhibition. There are currently no known clinical indications or commercial development partners associated with this compound.

Other names
CRA17693CRA-17693CRA 17693
02

Targets

PRSS1 (Trypsin family)

Beyond the preview

Go deeper on CRA_17693.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRA_17693.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call